Phio Pharmaceuticals (PHIO) Short Interest Ratio & Short Volume → top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL) (From Traders Agency) (Ad) Free PHIO Stock Alerts $0.67 -0.03 (-4.28%) (As of 04/24/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Phio Pharmaceuticals Short Interest DataCurrent Short Volume21,400 sharesPrevious Short Volume176,600 sharesChange Vs. Previous Month-87.88%Dollar Volume Sold Short$14,552.00Short Interest Ratio / Days to Cover0.1Last Record DateMarch 31, 2024Outstanding Shares4,590,000 sharesFloat Size4,510,000 sharesShort Percent of Float0.47%Today's Trading Volume91,423 sharesAverage Trading Volume452,984 sharesToday's Volume Vs. Average20% Short Selling Phio Pharmaceuticals ? Sign up to receive the latest short interest report for Phio Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatPHIO Short Interest Over TimePHIO Days to Cover Over TimePHIO Percentage of Float Shorted Over Time Ad Paradigm PressBitcoin Rockets To Record High But Buy THIS InsteadRecently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…>>Click here to find out what it is. Phio Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 3/31/202421,400 shares $14,552.00 -87.9%0.5%0.1 $0.68 3/15/2024176,600 shares $167,593.40 +283.9%7.4%0.6 $0.95 2/29/202446,000 shares $49,680.00 -30.0%1.9%0.1 $1.08 2/15/202465,700 shares $42,705.00 +390.3%2.7%0.1 $0.65 1/31/202413,400 shares $7,959.60 -74.1%0.6%0 $0.59 1/15/202451,800 shares $35,700.56 -66.4%2.2%0.1 $0.69 Get the Latest News and Ratings for PHIO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Phio Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 12/31/2023154,200 shares $117,192.00 +23.8%6.4%0.1 $0.76 12/15/2023124,600 shares $94,696.00 +783.7%5.2%0.1 $0.76 11/30/202314,100 shares $15,418.35 -35.0%0.6%0 $1.09 11/15/202321,700 shares $22,568.00 -35.2%0.9%0 $1.04 10/31/202333,500 shares $41,540.00 -91.2%1.5%0 $1.24 10/15/2023379,900 shares $566,051.00 +1,920.7%17.4%0.4 $1.49 9/30/202318,800 shares $28,388.00 +8.7%0.9%0.8 $1.51 9/15/202317,300 shares $28,545.00 +17.7%0.8%0.6 $1.65 8/31/202314,700 shares $31,311.00 +19.5%0.7%0.5 $2.13 8/15/202312,300 shares $27,675.00 +2.5%0.6%0.2 $2.25 7/31/202312,000 shares $32,040.00 -60.0%0.8%0 $2.67 7/15/202330,000 shares $81,900.00 +18.1%2.0%0.1 $2.73 6/30/202325,400 shares $72,898.00 -71.9%1.7%0 $2.87 6/15/202390,300 shares $295,281.00 -12.6%6.1%0.2 $3.27 5/31/2023103,300 shares $361,550.00 +588.7%7.0%0.2 $3.50 5/15/202315,000 shares $50,550.00 -49.8%1.0%0 $3.37 4/30/202329,900 shares $101,062.00 +116.7%2.7%0.2 $3.38 4/15/202313,800 shares $70,816.08 -25.4%1.2%0.1 $5.13 3/31/202318,500 shares $103,970.00 -39.5%1.7%0.8 $5.62 3/15/202330,600 shares $174,132.36 -30.6%2.8%0.8 $5.69 2/28/202344,100 shares $241,668.00 +3.5%4.1%1.2 $5.48 2/15/202342,600 shares $221,520.00 +27.5%3.9%1.2 $5.20 1/31/202333,400 shares $207,808.12 -91.0%3.0%1.1 $6.22 1/15/2023370,600 shares $199,678.91 +305.9%2.8%1.4 $0.54 12/30/202291,300 shares $33,963.60 +157.2%0.7%0.4 $0.37 12/15/202235,500 shares $12,783.55 +7.3%0.3%0.3 $0.36 11/30/202233,100 shares $13,902.00 -14.7%0.3%0.5 $0.42 11/15/202238,800 shares $17,479.40 -38.1%0.3%0.5 $0.45 10/31/202262,700 shares $36,052.50 -35.6%0.5%0.8 $0.58 10/15/202297,300 shares $54,244.75 +19.2%0.7%1.1 $0.56 9/30/202281,600 shares $46,618.08 -6.5%0.6%0.9 $0.57 9/15/202287,300 shares $64,785.33 +46.7%0.7%0.8 $0.74 8/31/202259,500 shares $41,667.85 -31.6%0.4%0.5 $0.70 8/15/202287,000 shares $66,468.00 +0.8%0.7%0.5 $0.76Bitcoin Rockets To Record High But Buy THIS Instead (Ad)Recently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…>>Click here to find out what it is. PHIO Short Interest - Frequently Asked Questions What is Phio Pharmaceuticals' current short interest? Short interest is the volume of Phio Pharmaceuticals shares that have been sold short but have not yet been covered or closed out. As of March 31st, investors have sold 21,400 shares of PHIO short. 0.47% of Phio Pharmaceuticals' shares are currently sold short. Learn More on Phio Pharmaceuticals' current short interest. What is a good short interest percentage for Phio Pharmaceuticals? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.47% of Phio Pharmaceuticals' floating shares are currently sold short. Is Phio Pharmaceuticals' short interest increasing or decreasing? Phio Pharmaceuticals saw a decrease in short interest in the month of March. As of March 31st, there was short interest totaling 21,400 shares, a decrease of 87.9% from the previous total of 176,600 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Phio Pharmaceuticals' float size? Phio Pharmaceuticals currently has issued a total of 4,590,000 shares. Some of Phio Pharmaceuticals' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Phio Pharmaceuticals currently has a public float of 4,510,000 shares. How does Phio Pharmaceuticals' short interest compare to its competitors? 0.47% of Phio Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Phio Pharmaceuticals: Atreca, Inc. (0.37%), Revelation Biosciences, Inc. (8.34%), Aravive, Inc. (1.81%), 60 Degrees Pharmaceuticals, Inc. (0.75%), GeoVax Labs, Inc. (0.31%), Virpax Pharmaceuticals, Inc. (3.42%), Agile Therapeutics, Inc. (12.68%), Mustang Bio, Inc. (2.35%), Evoke Pharma, Inc. (0.78%), TransCode Therapeutics, Inc. (0.61%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: TC Energy Co. ($4.49 billion), T-Mobile US, Inc. ($3.94 billion), General Motors ($3.34 billion), Charter Communications, Inc. ($3.32 billion), Occidental Petroleum Co. ($3.21 billion), Super Micro Computer, Inc. ($3.13 billion), Coinbase Global, Inc. ($3.08 billion), Moderna, Inc. ($2.28 billion), Tractor Supply ($2.24 billion), and Royal Caribbean Cruises Ltd. ($2.14 billion). View all of the most shorted stocks. What does it mean to sell short Phio Pharmaceuticals stock? Short selling PHIO is an investing strategy that aims to generate trading profit from Phio Pharmaceuticals as its price is falling. PHIO shares are trading down $0.03 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Phio Pharmaceuticals? A short squeeze for Phio Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of PHIO, which in turn drives the price of the stock up even further. How often is Phio Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including PHIO, twice per month. The most recent reporting period available is March, 31 2024. More Short Interest Resources from MarketBeat Related Companies: Atreca Short Squeeze Revelation Biosciences Short Squeeze Aravive Short Squeeze 60 Degrees Pharmaceuticals Short Squeeze GeoVax Labs Short Squeeze Virpax Pharmaceuticals Short Squeeze Agile Therapeutics Short Squeeze Mustang Bio Short Squeeze Evoke Pharma Short Squeeze TransCode Therapeutics Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:PHIO) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersHe Is Giving Away BitcoinCrypto Swap ProfitsBitcoin Rockets To Record High But Buy THIS InsteadParadigm Presstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyThe #1 Crypto for 2024InvestorPlaceEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest MetalsFed launches fourth dollar overhaulStansberry ResearchUrgent Alert: Biden's IRS Targeting Your Money – Act Fast to Protect It!American Alternative1970’s computer coder issues shocking A.I. warningTradeSmith